Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Facteur croissance endothélium vasculaire")


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 10831

  • Page / 434

Selection :

  • and

Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasisBJÖRNDAHL, Meit A; RENHAI CAO; BURTON, Jeremy B et al.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9261-9268, issn 0008-5472, 8 p.Article

Effect of glycodelin on the production of vascular endothelial growth factor in cumulus cellsHAYES, Ellen C; DOMINGUEZ, Celia E; VOELKEL, Steven et al.Fertility and sterility. 2006, Vol 85, Num 5, pp 1553-1556, issn 0015-0282, 4 p.Conference Paper

VEGF-Induced Vascular Permeability Is Mediated by FAKXIAO LEI CHEN; NAM, Ju-Ock; GUAN, Jun-Lin et al.Developmental cell. 2012, Vol 22, Num 1, pp 146-157, issn 1534-5807, 12 p.Article

Vascular endothelial growth factor and its relationship to inflammatory mediatorsANGELO, Laura S; KURZROCK, Razelle.Clinical cancer research. 2007, Vol 13, Num 10, pp 2825-2830, issn 1078-0432, 6 p.Article

Vascular endothelial growth factor: Basic science and clinical progressFERRARA, Napoleone.Endocrine reviews. 2004, Vol 25, Num 4, pp 581-611, issn 0163-769X, 31 p.Article

Docosapentaenoic acid (22 :5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factorTSUJI, Masako; MUROTA, Se-Itsu; MORITA, Ikuo et al.Prostaglandins, leukotrienes and essential fatty acids. 2003, Vol 68, Num 5, pp 337-342, issn 0952-3278, 6 p.Article

VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants : relationship to retinopathy of prematurityPIEH, C; AGOSTINI, H; BUSCHBECK, C et al.British journal of ophthalmology. 2008, Vol 92, Num 5, pp 689-693, issn 0007-1161, 5 p.Article

Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseasesASATO, Ryo; KITA, Takeshi; KAWAHARA, Shuhei et al.British journal of ophthalmology. 2011, Vol 95, Num 12, pp 1745-1748, issn 0007-1161, 4 p.Article

Retiform Hemangioendotheliomas Usually do not Express D2-40 and VEGFR-3PARSONS, Amy; SHEEHAN, Daniel Joseph; SANGUEZA, Omar P et al.The American journal of dermatopathology. 2008, Vol 30, Num 1, pp 31-33, issn 0193-1091, 3 p.Article

Structural determinants of vascular endothelial growth factor-D receptor binding and specificityLEPPÄNEN, Veli-Matti; JELTSCH, Michael; ANISIMOV, Andrey et al.Blood. 2011, Vol 117, Num 5, pp 1507-1515, issn 0006-4971, 9 p.Article

EG-VEGF: a key endocrine factor in placental developmentBROUILLET, Sophie; HOFFMANN, Pascale; FEIGE, Jean-Jacques et al.Trends in endocrinology and metabolism. 2012, Vol 23, Num 10, pp 501-508, issn 1043-2760, 8 p.Article

THE ROLE OF THE VEGF-ISOFORMS IN PATHOLOGICAL CHOROIDAL/RETINAL ANGIOGENESIS : 2010 FRO PROJECTSVAN DE VEIRE, S; VAN BERGEN, T; VANDEWALLE, E et al.Bulletin de la Société belge d'ophtalmologie. 2011, Num 317, issn 0081-0746, p. 55Article

Inhibition of tumor-induced edema by antisense VEGF is mediated by suppressive vesiculo-vacuolar organelles (VVO) formationZHI XIONG LIN; LI JUAN YANG; QIAN HUANG et al.Cancer science. 2008, Vol 99, Num 12, pp 2540-2546, issn 1347-9032, 7 p.Article

Bevacizumab 5 mg/kg can be infused safely over 10 minutesREIDY, Diane L; CHUNG, Ki Y; TIMONEY, John P et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2691-2695, issn 0732-183X, 5 p.Article

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrierAMBATI, Balamurali K; PATTERSON, Emory; JANI, Pooja et al.British journal of ophthalmology. 2007, Vol 91, Num 4, pp 505-508, issn 0007-1161, 4 p.Article

Vascular endothelial growth factor localization in the adultMAHARAJ, Arindel S. R; SAINT-GENIEZ, Magali; MALDONADO, Angel E et al.The American journal of pathology. 2006, Vol 168, Num 2, pp 639-648, issn 0002-9440, 10 p.Article

Vascular endothelial growth factor signaling pathways : Therapeutic perspectiveKOWANETZ, Marcin; FERRARA, Napoleone.Clinical cancer research. 2006, Vol 12, Num 17, pp 5018-5022, issn 1078-0432, 5 p.Article

The role of adrenomedullin in angiogenesisRIBATTI, Domenico; NICO, Beatrice; SPINAZZI, Raffaella et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 9, pp 1670-1675, issn 0196-9781, 6 p.Article

VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedemaWARE, L. B; KANER, R. J; CRYSTAL, R. G et al.The European respiratory journal. 2005, Vol 26, Num 1, pp 101-105, issn 0903-1936, 5 p.Article

Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptorJIAZHI SUN; BLASKOVICH, Michelle A; MULLAN, Michael et al.Cancer research (Baltimore). 2004, Vol 64, Num 10, pp 3586-3592, issn 0008-5472, 7 p.Article

Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factorPUFE, Thomas; LEMKE, Angelika; KURZ, Bodo et al.The American journal of pathology. 2004, Vol 164, Num 1, pp 185-192, issn 0002-9440, 8 p.Article

Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicleKOZLOWSKA, U; BLUME-PEYTAVI, U; KODELJA, V et al.Archives of dermatological research (Print). 1998, Vol 290, Num 12, pp 661-668, issn 0340-3696Article

Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic RetinopathyTITCHENELL, Paul M; ANTONETTI, David A.Diabetes (New York, NY). 2013, Vol 62, Num 6, pp 1808-1815, issn 0012-1797, 8 p.Article

Vascular Endothelial Growth Factor-A and Islet Vascularization Are Necessary in Developing, but Not Adult, Pancreatic IsletsREINERT, Rachel B; BRISSOVA, Marcela; MCGUINNESS, Owen P et al.Diabetes (New York, NY). 2013, Vol 62, Num 12, pp 4154-4164, issn 0012-1797, 11 p.Article

Nouvelle thérapie antiangiogénique indépendante du VEGF qui cible le récepteur CD160 = A novel VEGF-independent antiangiogenic therapy targeting the CD160 receptorLE BOUTEILLER, Philippe; TABIASCO, Julie; GIUSTINIANI, Jérôme et al.MS. Médecine sciences. 2012, Vol 28, Num 1, pp 37-38, issn 0767-0974, 2 p.Article

  • Page / 434